Table 1.
Demographics and clinical characteristics of the BRASS cohort at study entry (N = 1092)
| Variable | Numerical Values |
|---|---|
| Age, years (mean, SD) | 56.5 (13.7) |
| Gender (female) (N, %) | 894 (81.9) |
| Education (college or more) (N, %) | 632 (58.1) |
| Race (white) (N, %) | 1006 (92.8) |
| Corticosteroid use (N, %) | 306 (28.0) |
| Anti‐TNF use (N, %) | 411 (37.7) |
| Methotrexate use (N, %) | 562 (51.5) |
| Physically active (N,%) | 138 (12.7) |
| DAS28‐CRP3 (mean, SD) | 3.6 (1.6) |
| Depression score (MHI‐D) (3‐15)a (mean, SD) | 12.5 (2.1) |
| Fatigue (VAS) (0‐100)a (mean, SD) | 39.1 (28.7) |
| Sleep difficulties (MDHAQ) (0‐3)a (mean, SD) | 0.8 (0.8) |
| Cardiovascular disease (N, %) | 99 (8.1) |
| Disease duration, y (mean, SD) | 12.8 (11.9) |
| BMI (mean, SD) | 26.8 (5.7) |
Abbreviation: BMI, body mass index; MDHAQ, Multidimensional Health Assessment Questionnaire; MHI‐D, Mental Health Index‐Depression; TNF, tumor necrosis factor; VAS, visual analog scale.
aHigher score indicates worse value.